Literature DB >> 30606684

Impact of expanding indications on surgical and oncological outcome in 1434 consecutive pancreatoduodenectomies.

Stijn van Roessel1, Tara M Mackay1, Johanna A M G Tol1, Otto M van Delden2, Krijn P van Lienden2, Chung Y Nio3, Saffire S K S Phoa3, Paul Fockens4, Jeanin E van Hooft4, Joanne Verheij5, Johanna W Wilmink6, Thomas M van Gulik1, Dirk J Gouma1, Olivier R Busch1, Marc G Besselink7.   

Abstract

BACKGROUND: Over the years, high-volume pancreatic centers expanded their indications for pancreatoduodenectomy (PD) but with unknown impact on surgical and oncological outcome.
METHODS: All consecutive PDs performed between 1992-2017 in a single pancreatic center were identified from a prospectively maintained database and analyzed according to three time periods.
RESULTS: In total, 1434 patients underwent PD. Over time, more elderly patients underwent PD (P < 0.001) with increased use of vascular resection (10.4 to 16.0%, P < 0.001). In patients with cancer (n = 1049, 74.8%), the proportion pT3/T4 tumors increased from 54.3% to 70.6% over time (P < 0.001). The postoperative pancreatic fistula (16.0%), postpancreatectomy hemorrhage (8.0%) and delayed gastric emptying (31.0%) rate did not reduce over time, whereas median length of stay decreased from 16 to 12 days (P < 0.001). The overall failure-to-rescue rate (6.9%) and in-hospital mortality (2.2%) remained stable (P = 0.89 and P = 0.45). In 523 patients with pancreatic cancer (36.5%), the use of both adjuvant and neoadjuvant chemotherapy increased over time (both p<0.001), and the five-year overall survival improved from 11.0% to 17.4% (P < 0.001).
CONCLUSIONS: In a period where indications for PD expanded, with more elderly patients, more advanced cancers and increased use of vascular resections, surgical outcome remained favorable and five-year survival for pancreatic cancer improved.
Copyright © 2018 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30606684     DOI: 10.1016/j.hpb.2018.10.020

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  3 in total

1.  Hepatic vascular anomalies during totally laparoscopic pancreaticoduodenectomy: challenging the challenge.

Authors:  Alessandro Giani; Michele Mazzola; Lorenzo Morini; Andrea Zironda; Camillo Leonardo Bertoglio; Paolo De Martini; Carmelo Magistro; Giovanni Ferrari
Journal:  Updates Surg       Date:  2021-08-18

2.  Contemporary Surgical, Oncological, and Survival Outcomes of Pancreaticoduodenectomy for Periampullary Tumours: a 5-Year Experience from Tertiary Cancer Center.

Authors:  Ravi Arjunan; S D S Karthik; Ramachandra Chowdappa; Syed Althaf; Chunduri Srinivas
Journal:  Indian J Surg Oncol       Date:  2021-08-16

3.  Postoperative and long-term survival in relation to life-expectancy after pancreatic surgery in elderly patients (cohort study).

Authors:  S K Burgdorf; J H Storkholm; I M Chen; C P Hansen
Journal:  Ann Med Surg (Lond)       Date:  2021-08-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.